Shuo Liu

9.8k total citations · 3 hit papers
71 papers, 3.5k citations indexed

About

Shuo Liu is a scholar working on Infectious Diseases, Molecular Biology and Epidemiology. According to data from OpenAlex, Shuo Liu has authored 71 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 16 papers in Molecular Biology and 9 papers in Epidemiology. Recurrent topics in Shuo Liu's work include SARS-CoV-2 and COVID-19 Research (29 papers), COVID-19 Clinical Research Studies (10 papers) and SARS-CoV-2 detection and testing (9 papers). Shuo Liu is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (29 papers), COVID-19 Clinical Research Studies (10 papers) and SARS-CoV-2 detection and testing (9 papers). Shuo Liu collaborates with scholars based in China, United States and United Kingdom. Shuo Liu's co-authors include Bing Xiang Yang, Dan Luo, Joan E. Haase, Qiaohong Guo, Jiong Yang, Zhongchun Liu, Xiao Qin Wang, Qian Liu, Lin Xia and Weijin Huang and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Shuo Liu

67 papers receiving 3.5k citations

Hit Papers

The experiences of health-care providers during the COVID... 2020 2026 2022 2024 2020 2020 2021 250 500 750 1000

Peers

Shuo Liu
Kai Sen Tan Singapore
Jing Yang China
Peng Wu Hong Kong
Wei Hou China
Chi‐Hong Tseng United States
Elizabeth Spencer United Kingdom
Kai Sen Tan Singapore
Shuo Liu
Citations per year, relative to Shuo Liu Shuo Liu (= 1×) peers Kai Sen Tan

Countries citing papers authored by Shuo Liu

Since Specialization
Citations

This map shows the geographic impact of Shuo Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuo Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuo Liu more than expected).

Fields of papers citing papers by Shuo Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuo Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuo Liu. The network helps show where Shuo Liu may publish in the future.

Co-authorship network of co-authors of Shuo Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Shuo Liu. A scholar is included among the top collaborators of Shuo Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuo Liu. Shuo Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Guangming, Zisheng Guo, Shuo Liu, et al.. (2025). Bacteriophage application in inhibiting corrosion- producing bacteria. BMC Microbiology. 25(1). 241–241.
2.
Liu, Shuo, et al.. (2025). Startup acquisitions: Acquihires and talent hoarding. European Economic Review. 178. 105103–105103.
3.
Liu, Shuo, Pan Liu, Li Zhang, et al.. (2025). The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS‐CoV‐2 Omicron Variants. Journal of Medical Virology. 97(3). e70242–e70242. 1 indexed citations
4.
Wang, Yan‐Ning, Yuanyuan Xie, Dong Chen, et al.. (2023). Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies. Cell & Bioscience. 13(1). 160–160. 2 indexed citations
6.
Jiang, Fang, et al.. (2023). Significance of the FGFR3 mutation in Chinese patients with bladder cancer. Translational Andrology and Urology. 12(5). 761–769. 3 indexed citations
7.
Hu, Jialei, Yueyue Liu, Shuo Liu, et al.. (2023). Safety and immunogenicity of a modified Omicron-adapted inactivated vaccine in healthy adults: a randomized, double-blind, active-controlled Phase III clinical trial. Frontiers in Immunology. 14. 1241153–1241153. 4 indexed citations
8.
Wang, Bolun, Shuo Liu, Xinyu He, et al.. (2022). ACE2 decoy receptor generated by high-throughput saturation mutagenesis efficiently neutralizes SARS-CoV-2 and its prevalent variants. Emerging Microbes & Infections. 11(1). 1488–1499. 7 indexed citations
9.
Li, Qianqian, Li Zhang, Ziteng Liang, et al.. (2022). Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses. Signal Transduction and Targeted Therapy. 7(1). 256–256. 8 indexed citations
10.
Jin, Shuang, et al.. (2021). Stumbling and Growing: A Bibliometric Study of Academic Publications of Palliative Care in Mainland China for 2010–2020. Journal of Palliative Care. 37(2). 226–232. 8 indexed citations
11.
Zhang, Li, Qianqian Li, Ziteng Liang, et al.. (2021). The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron. Emerging Microbes & Infections. 11(1). 1–5. 248 indexed citations breakdown →
12.
Liu, Shuo, Lin Kang, Xiaohong Liu, et al.. (2021). Trajectory and Correlation of Intrinsic Capacity and Frailty in a Beijing Elderly Community. Frontiers in Medicine. 8. 751586–751586. 53 indexed citations
13.
Wang, Shilei, Shuo Liu, Yichi Zhang, et al.. (2020). Human Serum Albumin (HSA) and ItsApplications as a Drug Delivery Vehicle. ICUS and Nursing Web Journal. 14(2). 19 indexed citations
14.
Li, Qianqian, Jiajing Wu, Jianhui Nie, et al.. (2020). The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity. Cell. 182(5). 1284–1294.e9. 957 indexed citations breakdown →
15.
Liu, Qian, Dan Luo, Joan E. Haase, et al.. (2020). The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. The Lancet Global Health. 8(6). e790–e798. 1101 indexed citations breakdown →
16.
Liu, Shuo, et al.. (2019). Geptop 2.0: An Updated, More Precise, and Faster Geptop Server for Identification of Prokaryotic Essential Genes. Frontiers in Microbiology. 10. 1236–1236. 33 indexed citations
17.
Dong, Ming, Dandan Ye, Qicheng Liu, et al.. (2019). Cathepsin C promotes the progression of periapical periodontitis. Science Bulletin. 65(11). 951–957. 7 indexed citations
18.
Feng, Baihuan, Lijuan Li, Hongbing Xu, et al.. (2018). PM2.5-bound polycyclic aromatic hydrocarbons (PAHs) in Beijing: Seasonal variations, sources, and risk assessment. Journal of Environmental Sciences. 77. 11–19. 121 indexed citations
19.
Browning, Colette, Hui Yang, Tuohong Zhang, et al.. (2015). Implementing a Chronic Disease Self-Management Program into China: The Happy Life Club™. Frontiers in Public Health. 2. 181–181. 16 indexed citations
20.
Li, Jie, Yun Zhang, Meng Liu, et al.. (2012). Identification and thermal stability of purple-fleshed sweet potato anthocyanins in aqueous solutions with various pH values and fruit juices. Food Chemistry. 136(3-4). 1429–1434. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026